Ancrod for coronary angioplasty.
Anticoagulation in the form of intravenous heparin is used after coronary angioplasty to prevent thrombosis. Ancrod, a rapid-acting defibrinogenating agent, has been used in various clinical settings that require anticoagulation. We present the use of ancrod after percutaneous transluminal coronary...
保存先:
| 出版年: | Tex Heart Inst J |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Texas Heart Institute
1995
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC325287/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8605439/ |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|